Status | Study |
Terminated |
Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Condition: Gastrinoma Glucagonoma Insulinoma Date: 2014-01-07 Interventions: Drug: everolimus Given PO |
Available |
Study Name: 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia Condition: Congenital Hyperinsulinism Beckwith-Wiedemann Syndrome Date: 2013-07-30 Interventions: Drug: 18F-DOPA 18F-DOPA is a PET scan radiotracer. |
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2013-04-02 Interventions: Drug: temozolomide Given PO |
Active, not recruiting |
Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2012-01-10 Interventions: Drug: capecitabine Given PO |
Completed |
Study Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Condition: Gastrin-Producing Neuroendocrine Tumor Lung Carcinoid Tumor Date: 2010-09-16 Interventions: Biological: Cixutumumab Given |
Active, not recruiting |
Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condition: Adult Hepatocellular Carcinoma Advanced Adult Hepatocellular Carcinoma Date: 2009-11-06 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients Condition: Hyperinsulinism Hypoglycemia Insulin Date: 2009-07-02 Interventions: Other: 111In-exendin-4 imaging 90-100 megabecquerel (MBq) (30 microgram or less) 111In-exendin-4 IV once |
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2008-04-09 Interventions: Drug: everolimus Given orally |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition: Gastrin-Producing Neuroendocrine Tumor Lung Carcinoid Tumor Date: 2007-03-27 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insulinoma Date: 2005-08-16 Interventions: Drug: sorafenib tosylate 400 mg given orally Other N |